Pharmaceutical Glass Packaging

Global Market Trajectory & Analytics

MCP13956

EXECUTIVE ENGAGEMENTS

OUTREACH

594
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

119
Interactions with Platform & by Email

PARTICIPANTS

24
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPETITORS

41
Responses Validated*

BRANDS

163
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

210

PAGES

377

EDITION

7

PRICE

USD $4950


  

HIGHLIGHTS

The global market for Pharmaceutical Glass Packaging is expected to reach US$26.6billion by the year 2027, trailing a post COVID-19 CAGR of 7.9% over the analysis period 2020 to 2027.Glass is made up of 59-80% silica, 5-12% calcium oxide, 12-17% sodium oxide, & 0.5-3.0% aluminum oxide, barium oxide, boric oxide, potassium oxide & magnesium oxide. Glass is the perfect packaging material of choice for 21st-century drugs. Glass is heat resistant & is easy to sterilize. Uniform surface chemistry makes glass more resistant to damage & breakage. Glass is chemically durable & is well suited to protect sensitive drug compounds. Glass ensures drug sterility & reduces the risk of global drug product recalls, supply interruptions & drug shortage. The U.S is expected to witness pharmaceutical glass manufacturing return to the country supported by the Trump government's protectionist policies. COVID-19 induced rethinking of global drug supply chains & escalating tensions between China & the USA will accelerate the reshoring trend. In support of the world's focus on development of COVID-19 vaccine, pharmaceutical packaging is also scaling up operations to keep pace with the ongoing efforts in the space. Companies engaged in development of COVID-19 vaccines are inking agreements with various for making syringes and vials to package the COVID-19 vaccine.


Moderna for instance announced a collaborative deal with Catalent in June 2020 for providing vial filling and packaging for initial batch of 100 million doses of vaccine from its US facility in Indiana. The company is expected to produce around 500 million to 1 billion doses annually, starting in 2021 from its US-based production facility, through a strategic partnership with Lonza, enhancing the need for packaging solutions. With the rising incidence of COVID-19 infections all over the world, and the mounting economic and social impacts, the vaccine development initiatives are progressing at a breathtaking pace, inching towards the final trials and commercial production of promising vaccine candidates by the end of 2020 or early 2021. The imperative need to develop a vaccine to curb the highly infectious COVID-19 virus is leading has cut short the vaccine development cycle significantly. Banking upon the extensive research happening worldwide, strategic public-private development partnerships are on the rise across geographies, universities, pharmaceutical industries and public health agencies, coupled with rising government and other funding so as to fast track requisite trial phases, thereby gearing up for quicker manufacturing approvals for promising vaccine. Presently, around 142 experimental vaccines are under studies, focusing on diverse technologies, to efficiently assess clinical outcomes across board. Irrespective of the diverse platforms, the development haste is all set to augur well for the production of vaccine in the near term. About 13 vaccines have entered human trials to test the safety and efficacy of the vaccine on healthy volunteers, while 129 are in pre-clinical animal trial studies.


With COVID-19 vaccines moving into late stage testing, pharma majors and governments around the world are looking to ensure packaging supplies for the vaccines. SiO2 Materials Science announced $163 million investment for increasing production capacity of syringes and vials for COVID-19 vaccines and drugs. This investment is in addition to $143 million contract with BARDA, and is intended to prevent any shortage of glass vials that could impede distribution efforts related to COVID-19 vaccine. SiO2's investment will be directed at building a new injection molding facility. Stevanato inked a deal with the Coalition for Epidemic Preparedness Innovations (CEPI), whereby Stevanato will provide supplies of 100 million Type 1 Borosilicate glass vials for packaging of 2 billion doses of COVID-19 vaccine. The US government has already started investments in required manufacturing capacity. The Operation Warp Speed along with industry participants is making efforts to advance production capacity while vaccine candidates are still in the testing phase, rather than scaling up the capacity after authorization or regulatory approval. The HHS has signed agreements with Moderna, Johnson & Johnson, and AstraZeneca for investment in manufacturing capacities. The HHS has also signed deal with Emergent BioSolutions for advancing local manufacturing capacity for the potential COVID-19 vaccine and therapeutics. The program is set to devise plans and required infrastructure to support distribution. Operation Warp Speed is expected to ensure availability of necessary resources and materials such as glass vials for vaccine distribution. The HHS and Department of Defense have signed a $138 million agreement with ApiJect for distribution of over 100 million prefilled syringes in the US by the end of 2020 along with the capacity to produce more than 500 million prefilled syringes by 2021. The departments are also making efforts to boost local production of vials. In addition to signing a $204 million deal with Corning to produce 164 million Valor Glass vials per year, the agencies have provided a $143 million contract to SiO2 Materials Science for producing glass-coated plastic container for vaccines and drugs. The US spent around $110 million for procuring syringes and needles for mass vaccination and protect against COVID-19.

SELECT PLAYERS

Arab Pharmaceutical Glass Co.; Ardagh Group S.A.; Beatson Clark; Bormioli Rocco SpA; Corning, Inc.; Gerresheimer AG; Nipro Corporation; Piramal Glass; SCHOTT Pharmaceutical Packaging; SGD Pharma; Shandong Qidu Pharmaceutical Co., Ltd.; Sisecam Group; Stevanato Group S.p.A.; Stölzle-Oberglas Gmbh; West Pharmaceutical Services, Inc.

SEGMENTS

» Product Type (Bottles, Vials, Ampoules, Cartridges & Syringes) » Drug Type (Generic, Branded, Biologic)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
COVID-19 Impact on Pharmaceutical Packaging Market
EXHIBIT: Growing COVID-19 Cases and Efforts to Develop Vaccines Presents Opportunity for Pharmaceutical Glass Packaging Market: Top Countries Ranked by Number of COVID-19 Cases
COVID-19 to Restructure the Pharmaceutical Supply Chain Management
Pharmaceutical Companies Devise Innovative Strategies for Streamlining Supply Chain Networks
Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand for Glass Packaging
EXHIBIT: COVID-19 Vaccines in Pipeline by Technology and Clinical Stage
Efforts to Boost Manufacturing of Glass Vials and Prefilled Syringes for COVID-19 Vaccine Gain Traction
Fears of Glass Vial Shortage Prompts Flurry of Industry Activities
Glass Packaging: Sustainable, Green, and Pure Form of Packaging
An Introduction to Pharmaceutical Glass Packaging
Types of Glass Containers Used for Packaging in Pharmaceutical Industry
Pharmaceutical Glass Packaging Product Types
Key Advantages & Disadvantages of Glass Containers
Global Market Prospects & Outlook
Glass Bottles: The Largest Product Type
Generic Drugs Represent the Largest Segment
Developed Regions Lead the Pharmaceutical Glass Packaging Market
Growth of Pharmaceutical Manufacturing in Developing Economies Supports Market
Competition
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
EXHIBIT: Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
Rapid Growth of Generic Drugs Augurs Well for Glass Packaging Market
EXHIBIT: Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques
EXHIBIT: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
Aging Population, Increasing Burden of Chronic Disease and Consequent Rise in Demand for Injectables Drugs Augurs Well for Glass Packaging
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045)
Contract Packaging Trend Augurs Well for the Pharma Glass Packaging Market
Ampoules Emerge as a Preferred Packaging Option for Pharma Companies
Parenteral Packaging Market Drives Demand for Glass Vials & Ampoules
EXHIBIT: Parenteral Packaging Market by Product (in %) for 2020E
Silica Bottles Facilitate Targeted Drug Delivery
Innovative Glass Packaging Solutions Help Improve Quality of Drugs
Innovations & Advancements Drive Market Growth
SCHOTT Offers syriQ BioPure® and SCHOTT TOPPAC® Syringes
Corning Creates Boron-Free Valor® Glass
Recyclability and Sustainability Increases Commodity Value of Glass, Paving Way for Use in Pharma Sector
Impending Phase-out of Plastic Brings to Light the Importance of Glass for Pharmaceutical Packaging Companies
Glass Flakes: A Key Concern for the Pharmaceutical Glass Packaging Manufacturers
Aluminosilicate Glass Emerges as a Solution to the Issue of Glass Flakes
Product Recall Incidents Likely to Hamper Market Stability
Alternative Materials Present A Threat to Glass Packaging in Pharmaceutical Industry
EXHIBIT: Global Pharmaceutical Packaging Market by Material (in %): 2020E
High Cost of Glass Packaging Containers: A Major Market Restraint
EXHIBIT: Cost Breakdown for Container Glass by Components
Emphasis on Product Integrity Drives Need for Anti-Counterfeit Pharmaceutical Packaging
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Bottles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ampoules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cartridges & Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Branded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biologic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
Pharmaceutical Packaging Market in the US: An Overview
EXHIBIT: US Pharmaceutical Packaging Market by Material (in %) for 2020E
USA Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
CHINA
Market Overview
China Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
China Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
EUROPE
Europe Pharmaceutical Packaging: A Prelude
EXHIBIT: Europe Pharmaceutical Packaging Materials Market by Application (in %) for 2020E
Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
France Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Market Overview
Asia-Pacific to Witness Introduction of New Syringes and Ampoules
Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
INDIA
Indian Glass Vial Manufacturers Prepare for Demand Surge for Bottling COVID-19 Vaccines
Changing Product Portfolio Composition Drives Spending on Packaging
India Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
India Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
LATIN AMERICA
Vials and Ampoules to Witness Robust Demand in Latin America
Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2012, 2020 & 2027
Total Companies Profiled: 41

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com